Companion Animal Diagnostics Market is projected to reach US$ 8.80 Billion by 2031

Consumables Segment by Type to Bolster Companion Animal Diagnostics Market Growth During 2025–2031

According to our new research study on "Companion Animal Diagnostics Market Forecast to 2031 – Global Analysis – by Product, Companion Animal, Technology, Application, and End User," the market was valued at US$ 4.61 billion in 2024 and is projected to reach US$ 8.80 billion by 2031; it is anticipated to register a CAGR of 9.8% during 2025–2031.

The report emphasizes the companion animal diagnostics market trends, along with drivers and deterrents affecting the market growth. The upsurging companion animal healthcare expenditure and the growing pet humanization and ownership contribute to the increasing companion animal diagnostics market size. However, the high cost of diagnostic products and infrastructure hampers the market growth. Further, integration of digitalization and artificial intelligence in veterinary healthcare is expected to emerge as a new market trend in the coming years.

Companion Animal Diagnostics Market Share, by Region, 2024 (%)

Source: The Insight Partners Analysis

Upsurging Companion Animal Healthcare Expenditure Bolsters Companion Animal Diagnostics Market Growth

The expenditure on veterinary healthcare is rising across the world. Spending on pet healthcare is surging dramatically, including purchasing pet food supplies, over-the-counter pharmaceuticals, veterinarian treatment, and pet insurance coverage. The considerable increase in pet care expenditure is leading to the growing demand for pet insurance, especially in major markets throughout North America and Europe. According to the American Pet Products Association 2023–2024, there is an upsurge in expenses in the pet industry in the US, accounting for US$ 143.6 billion in 2023, compared to US$ 136.8 billion in 2018. This rise in pet expenditure accelerates the demand for their care products. According to the North American Pet Health Insurance Association Inc. data, in 2023, the total US pet insurance volume was US$ 3.2 billion. The total number of pets insured in the country at the end of 2022 was US$ 4.8 million, which was a rise of 22% from 2021.

Pet owners in Europe are spending more on various aspects of pet care, including food, products, services, and veterinary care. For instance, France spends an average of 1,224 euros (US$ 1,411) per pet annually. These aim to expedite clinical decisions with greater confidence by offering enhanced insights and tailored assistance. Several pet owners spend significantly on animal healthcare, particularly veterinary care, diagnostics, and pharmaceuticals. Pet health and preventive diagnostic testing are still in their early stages. The increasing healthcare expenditure on companion animals and the rising demand for insurance drive the demand for companion animal diagnostics market growth. 

Companion Animal Diagnostics Market Report Scope:

The companion animal diagnostics market analysis has been carried out by considering the following segments: product, companion animal, technology, application, end user, and geography. 

Based on product, the companion animal diagnostics market is segmented into consumables and instruments. The consumables segment held the largest companion animal diagnostics market share in 2024. Several diagnostic instruments need substantial upfront investment and maintenance; however, consumables offer a more affordable solution for veterinary clinics. These products contain test strips, slides, reagents, and ready-to-use kits that simplify complex diagnostic processes, allowing veterinarians to detect common diseases and monitor animal health. For instance, rapid antigen test kits for canine parvovirus or feline leukemia virus deliver results within minutes, facilitating timely treatment decisions and improving animal outcomes without requiring specialized equipment or extensive training. Consumables and reagents offer more flexibility and convenience than standalone diagnostic instruments. They can be readily transported, stocked, and utilized in mobile or remote veterinary services. Pet owners seek more accessible healthcare for their companion animals. These products can be tailored for precise diagnostic needs, assuring higher sensitivity and specificity for diseases or conditions common in pets. This adaptability, integrated with their cost-effectiveness and ease of use, makes consumables the preferred choice for many veterinarians.

Based on companion animal, the companion animal diagnostics market is segmented into dogs, cats, horses, and others. The dogs segment held the largest companion animal diagnostics market share in 2024. The prevalence of obesity, zoonotic diseases, cancer, and skin disorders is growing significantly in dogs. Moreover, the pet ownership and the number of companion animals in developed nations are rising. Dogs are more reliable than other companion animals, and the cost associated with veterinary care for dogs tends to be comparatively higher than for cats. The American Veterinary Medical Association declares that around one in four dogs develop neoplasia, and nearly half of dogs aged over ten have cancer. The incidence highlights the critical role of diagnostic services in effective canine health management. The adoption of dogs as companion animals has accelerated. As dogs are increasingly seen as part of the family, pet owners are becoming more attentive to their health needs. This change has led to an enhanced demand for advanced veterinary healthcare services. Pet owners are more likely to fund sophisticated health monitoring and diagnostic solutions to guarantee their pets’ well-being.

Based on technology, the companion animal diagnostics market is segmented into immunodiagnostics, molecular diagnostics, clinical biochemistry, hematology, urinalysis, and others. The immunodiagnostics segment held the largest companion animal diagnostics market share in 2024. Immunoassays are biochemical tests that use antigen-antibody binding reactions to detect the presence of specific molecules in the sample. The applications of immunoassay in veterinary science are vast. The immunodiagnostics include lateral flow assays, ELISA tests, allergen-specific immunodiagnostic tests, and immunoassay analyzers. Owing to the high specificity and sensitivity, these tests are anticipated to grow during the forecast period. Immunodiagnostic tests are a practical and widely used tool for analyzing animal diseases due to their expanding application areas, such as detecting arboviral disease.

An increase in multiple zoonoses, including bovine ephemeral fever, leptospirosis, Johne's diseases, viral respiratory tract infections, dermatophyte fungi, and infectious bovine rhinotracheitis, in companion animals is enabling the use of immunodiagnostics technologies, due to their high throughput capability, simplicity, time & cost-efficiency, field portability, and others. The increasing prevalence of companion animals and the rising demand for cutting-edge diagnostic tools drive the demand for immunodiagnostics. 

In terms of application, the companion animal diagnostics market is segmented into clinical pathology, bacteriology, parasitology, virology, and others. The clinical pathology segment dominated the market in 2024. The demand for complete pet insurance is increasing. This trend has spurred greater investment in diagnostic services to support early disease diagnosis and effective treatment. Clinical pathology tests are cost-effective and highly accessible.

Companion animals such as cats and dogs often suffer from chronic conditions such as diabetes and kidney disorders. This has led owners to depend more on clinical pathology for accurate diagnosis and management. Moreover, the incidence of chronic diseases such as rabies virus, skin disease is rising globally. The expanding veterinary healthcare sector and a rising number of veterinary professionals are driving the demand for clinical pathology labs and test kits. This method is used to identify infections, inflammatory conditions, and various cancers in animals through minimally invasive procedures such as fine needle aspiration. For instance, veterinarians often use clinical pathology to examine skin lumps or lymph node swellings in dogs and cats to determine if they are benign or malignant. The increasing demand for minimally invasive diagnostic methods is boosting the companion animal diagnostics market growth.

In terms of end user, the companion animal diagnostics market is segmented into diagnostic & reference laboratories, veterinary hospitals and clinics, research institutes, and others. The veterinary hospitals and clinics segment dominated the market in 2024. The rising adoption of technological innovations such as point-of-care diagnostics (POCD) enables faster, more accurate testing. These advancements allow for quicker detection and treatment of diseases, improving overall veterinary care. For instance, Symmetrical Dimethylarginine (SDMA) test kits enhanced by artificial intelligence (AI) assess kidney function in dogs and cats. These technologies significantly enhance diagnostic capabilities in veterinary practices.

The awareness of zoonotic diseases, which can be transmitted between animals and humans, is increasing. As the threat of these diseases becomes more recognized, there is a growing need for reliable tests to detect and manage infections. Veterinary hospitals and clinics safeguard animal and human health by providing early detection and treatment. This growing awareness has expanded the market for diagnostic services, especially for zoonotic disease management.

Global organizations such as the World Organization for Animal Health have been instrumental in setting standards to improve animal health and veterinary services. These initiatives encourage investments in diagnostic infrastructure, providing the public and private sectors with clear guidance. The increased focus on animal health standards supports companion animal diagnostics market growth, drives technological innovation, and improves diagnostic capabilities. As a result, the companion animal diagnostics market is expected to grow, particularly in zoonotic disease management and technological advancements.

Companion Animal Diagnostics Market Analysis: Based on Geography

The geographic scope of the companion animal diagnostics market includes the assessment of the market performance in North America (US, Canada, and Mexico), Europe (Spain, UK, Germany, France, Italy, and Rest of Europe), Asia Pacific (South Korea, China, India, Japan, Australia, and Rest of Asia Pacific), South & Central America (Brazil, Argentina, and Rest of South & Central America), and the Middle East & Africa (South Africa, Saudi Arabia, UAE, and Rest of Middle East & Africa).    

The Indian Veterinary Research Institute (IVRI), Animal Medicines Australia, American Veterinary Medical Association (AVMA), National Animal Health Monitoring System (NAHMS), Canadian Food Inspection Agency (CFIA), Assistance Dogs International (ADI), Directorate-General for Food (DGAL), and French National Animal Health Surveillance Platform (NAHSP) were among the primary and secondary sources referred to while preparing the companion animal diagnostics market report. 

Contact Us

Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com